Acuren (NYSE: TIC) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 500 percent. The company reported quarterly sales of $584.347 million which beat the analyst consensus estimate of $577.664 million by 1.16 percent. This is a 86.14 percent increase over sales of $313.925 million the same period last year.